Your browser doesn't support javascript.
loading
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease.
Kotecha, Dipak; Flather, Marcus D; Atar, Dan; Collins, Peter; Pepper, John; Jenkins, Elizabeth; Reid, Christopher M; Eccleston, David.
Afiliação
  • Kotecha D; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. d.kotecha@bham.ac.uk.
  • Flather MD; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Melbourne, Australia. d.kotecha@bham.ac.uk.
  • Atar D; Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.
  • Collins P; Department of Cardiology, Oslo University Hospital Ulleval, University of Oslo, Oslo, Norway.
  • Pepper J; Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK.
  • Jenkins E; Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK.
  • Reid CM; Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Eccleston D; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Melbourne, Australia.
BMC Med ; 17(1): 72, 2019 04 03.
Article em En | MEDLINE | ID: mdl-30943979
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Biomarcadores / Peptídeo Natriurético Encefálico Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Biomarcadores / Peptídeo Natriurético Encefálico Idioma: En Ano de publicação: 2019 Tipo de documento: Article